Bipolar disorder market

View All

fanapt-for-bipolar-disorder-treatment
Vanda Broadens its Reach to Bipolar Disorder Treatment Market With Fanapt Approval

Fifteen years after its first FDA approval for treating schizophrenia with Fanapt (iloperidone), Vanda Pharmaceuticals has achieved another success. Fanapt is a type of antipsychotic medication that deviates from the usual and has been administered to individuals with schizophrenia for their immediate treatment fol...

Find More

Schizophrenia vs Bipolar disorder: Biomarkers to the rescue
Schizophrenia vs Bipolar disorder: Biomarkers to the rescue

Schizophrenia and Bipolar disorder (BD) are most of the times difficult to distinguish. Schizophrenia is characterized by hallucinations, and delusions when a patient loses reality and feels detached. On the other hand, Bipolar disorder a person suffers from extreme phases of mood swings from sometimes depression t...

Find More

Bipolar disorder market
Increasing cases of Mania and Bipolar disorder market

Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American Psychiatric Association, there are four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipol...

Find More